These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36460182)

  • 1. Long-term Outcomes of Diffuse or Recurrent Tenosynovial Giant Cell Tumor Treated with Postoperative External Beam Radiation Therapy.
    Baniel C; Yoo CH; Jiang A; von Eyben R; Mohler DG; Ganjoo K; Bui N; Donaldson SS; Million L; van de Rijn M; Oh JM; Hiniker SM
    Pract Radiat Oncol; 2023; 13(3):e301-e307. PubMed ID: 36460182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical outcomes of patients with diffuse-type tenosynovial giant-cell tumours: an international, retrospective, cohort study.
    Mastboom MJL; Palmerini E; Verspoor FGM; Rueten-Budde AJ; Stacchiotti S; Staals EL; Schaap GR; Jutte PC; Aston W; Gelderblom H; Leithner A; Dammerer D; Takeuchi A; Thio Q; Niu X; Wunder JS; ; van de Sande MAJ
    Lancet Oncol; 2019 Jun; 20(6):877-886. PubMed ID: 31029509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome of the treatment of high-risk tenosynovial giant cell tumor/pigmented villonodular synovitis with radiotherapy and surgery.
    Griffin AM; Ferguson PC; Catton CN; Chung PW; White LM; Wunder JS; Bell RS; O'Sullivan B
    Cancer; 2012 Oct; 118(19):4901-9. PubMed ID: 22281719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extensile Anterior and Posterior Knee Exposure for Complete Synovectomy of Diffuse Tenosynovial Giant Cell Tumor (Pigmented Villonodular Synovitis).
    Lingamfelter M; Novaczyk ZB; Cheng EY
    JBJS Essent Surg Tech; 2022; 12(2):. PubMed ID: 36741035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Giant cell tumor of tendon sheath, tenosynovial giant cell tumor, and pigmented villonodular synovitis: defining the presentation, surgical therapy and recurrence.
    Martin RC; Osborne DL; Edwards MJ; Wrightson W; McMasters KM
    Oncol Rep; 2000; 7(2):413-9. PubMed ID: 10671695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. External beam radiation therapy enhances local control in pigmented villonodular synovitis.
    Horoschak M; Tran PT; Bachireddy P; West RB; Mohler D; Beaulieu CF; Kapp DS; Donaldson SS
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):183-7. PubMed ID: 19211195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Midterm outcomes of 18 patients with primary intra-articular diffuse tenosynovial giant cell tumor (TGCT) of the knee treated with complete arthroscopic synovectomy and postoperative low-dose radiotherapy at a mean follow-up of 68 months.
    Tie K; Wang H; Chen B; Yang X; Chen L
    Arch Orthop Trauma Surg; 2023 Apr; 143(4):2121-2127. PubMed ID: 35562595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct extra-articular invasion patterns of diffuse pigmented villonodular synovitis/tenosynovial giant cell tumor in the knee joints.
    Kim DE; Kim JM; Lee BS; Kim NK; Lee SH; Bin SI
    Knee Surg Sports Traumatol Arthrosc; 2018 Nov; 26(11):3508-3514. PubMed ID: 29637236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of advanced primary and recurrent diffuse pigmented villonodular synovitis of the knee.
    Chin KR; Barr SJ; Winalski C; Zurakowski D; Brick GW
    J Bone Joint Surg Am; 2002 Dec; 84(12):2192-202. PubMed ID: 12473708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incomplete resection increases the risk of local recurrence and negatively affects functional outcome in patients with tenosynovial giant cell tumor of the hindfoot.
    Tsukamoto S; Zucchini R; Staals EL; Mavrogenis AF; Akahane M; Palmerini E; Errani C; Tanaka Y
    Foot Ankle Surg; 2020 Oct; 26(7):822-827. PubMed ID: 31839476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose external beam radiotherapy as a postoperative treatment for patients with diffuse pigmented villonodular synovitis of the knee: 4 recurrences in 23 patients followed for mean 9 years.
    Park G; Kim YS; Kim JH; Lee SW; Song SY; Choi EK; Yi SY; Ahn SD
    Acta Orthop; 2012 Jun; 83(3):256-60. PubMed ID: 22489888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of tenosynovial giant cell tumour of the temporomandibular joint: a systematic review.
    Kanbour A; Hurrell M; Ricciardo P
    ANZ J Surg; 2023 Apr; 93(4):869-875. PubMed ID: 37052058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of Tenosynovial Giant Cell Tumor of the Foot and Ankle.
    Barnett JR; Rudran B; Khan A; O'Reilly-Harbidge S; Patel S; Malhotra K; Cullen N; Welck M; Aston W
    Foot Ankle Int; 2023 Oct; 44(10):1013-1020. PubMed ID: 37644900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tenosynovial giant cell tumour/pigmented villonodular synovitis: outcome of 294 patients before the era of kinase inhibitors.
    Palmerini E; Staals EL; Maki RG; Pengo S; Cioffi A; Gambarotti M; Picci P; Daolio PA; Parafioriti A; Morris C; Antonescu CR; Gronchi A; Casali PG; Donati DM; Ferrari S; Stacchiotti S
    Eur J Cancer; 2015 Jan; 51(2):210-7. PubMed ID: 25465190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Tenosynovial Giant Cell Tumor: A Neoplastic and Inflammatory Disease.
    Healey JH; Bernthal NM; van de Sande M
    J Am Acad Orthop Surg Glob Res Rev; 2020 Nov; 4(11):e20.00028. PubMed ID: 33156160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Image-guided, intensity-modulated radiotherapy for the treatment of diffuse-type tenosynovial giant cell tumor of the knee: Case report and review of the literature.
    Xiang X; Jiang W; Qiu C; Xiao N; Liang J
    Medicine (Baltimore); 2021 Jul; 100(28):e26659. PubMed ID: 34260572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tenosynovial giant cell tumors of the temporomandibular joint and lateral skull base: Review of 11 cases.
    Carlson ML; Osetinsky LM; Alon EE; Inwards CY; Lane JI; Moore EJ
    Laryngoscope; 2017 Oct; 127(10):2340-2346. PubMed ID: 27888510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome following radiation treatment for high-risk pigmented villonodular synovitis.
    O'Sullivan B; Cummings B; Catton C; Bell R; Davis A; Fornasier V; Goldberg R
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):777-86. PubMed ID: 7790264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. External beam radiotherapy as postoperative treatment of diffuse pigmented villonodular synovitis.
    Berger B; Ganswindt U; Bamberg M; Hehr T
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1130-4. PubMed ID: 17175116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined partial arthroscopic synovectomy and radiation therapy for diffuse pigmented villonodular synovitis of the knee.
    Blanco CE; Leon HO; Guthrie TB
    Arthroscopy; 2001 May; 17(5):527-31. PubMed ID: 11337722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.